# Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer

> **NCT00057759** · NA · COMPLETED · sponsor: **Radiation Therapy Oncology Group** · enrollment: 115 (actual)

## Conditions studied

- Prostate Cancer
- Psychosocial Effects of Cancer and Its Treatment
- Radiation Toxicity
- Sexual Dysfunction
- Sexuality and Reproductive Issues

## Interventions

- **DRUG:** sildenafil citrate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00057759
- **Lead sponsor:** Radiation Therapy Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-01
- **Primary completion:** 2006-12
- **Final completion:** —
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2015-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057759, "Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT00057759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*